Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
As the commonality of medical cannabis continues to increase in the UK, keeping ...
The approval allows adults with SLE on standard therapy to inject Saphnelo thems...
The deal was originally announced in December 2025. With the acquisition, BioMar...
Symposium focuses on translating research into clinical application in ophthalm...
Where the future of Indian Pharma takes shape. The post Express Pharma World Ex...
Appointment to focus on private equity and M&A advisory in life sciences secto...
Therapy targets gram-negative bacterial infections in critical care settings Th...
Mary Bridge Children’s Hospital is preparing for the grand opening of its new st...
How much drug product loss should you expect in fill-finish? Drug product loss i...
The European Commission (EC) has approved Novartis’ Rhapsido (remibrutinib) for ...
Organon, created through a spinoff from Merck & Co (MSD) in 2021, distributes mo...
Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmo...
Five-year agreement focuses on open science access, joint research and capabili...
Former Cipla CEO to lead next phase for CDMO platform focused on complex chemis...
The inaugural edition of FDD Conclave - Mumbai Connect, a city-focused platform...
Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; m...
